Back to top
more

Charles River Laboratories International (CRL)

(Delayed Data from NYSE)

$211.60 USD

211.60
681,775

+1.97 (0.94%)

Updated Jun 21, 2024 04:00 PM ET

After-Market: $211.55 -0.05 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (91 out of 249)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

1 item in cart

View Cart/Checkout

Charles River Laboratories International, Inc. [CRL]

Reports for Purchase

Showing records 101 - 120 ( 382 total )

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 101

06/11/2022

Company Report

Pages: 16

Optimized Entry and Exit Levels for CRL 61122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 102

06/09/2022

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 103

06/08/2022

Company Report

Pages: 7

Lowers 2Q22, No Concerning Reads on LONN, CTLT, TMO, CDMO

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 104

06/02/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 105

06/01/2022

Company Report

Pages: 16

Optimized Entry and Exit Levels for CRL 6122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 106

05/17/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 107

05/11/2022

Company Report

Pages: 17

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 108

05/09/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 109

05/05/2022

Daily Note

Pages: 22

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 110

05/04/2022

Company Report

Pages: 6

No Biopharma Weakness Here - 1Q22

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 111

04/25/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 112

04/21/2022

Company Report

Pages: 16

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 113

04/11/2022

Company Report

Pages: 16

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 114

04/11/2022

Daily Note

Pages: 7

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 115

04/10/2022

Daily Note

Pages: 17

Life Science, Bioproduction, CROs: Positive Data Points for 2023

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 116

04/08/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 117

04/07/2022

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 118

04/06/2022

Daily Note

Pages: 3

Expands CRADL Footprint; Adds 100bps of Revenue Tailwind

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 119

04/01/2022

Company Report

Pages: 16

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 120

03/22/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party